CME Group (NASDAQ:CME) Price Target Raised to $347.00 at Rothschild & Co Redburn

by · The Cerbat Gem

CME Group (NASDAQ:CME – Get Free Report) had its price target hoisted by analysts at Rothschild & Co Redburn from $333.00 to $347.00 in a research report issued on Thursday,MarketScreener reports. The brokerage currently has a “neutral” rating on the financial services provider’s stock. Rothschild & Co Redburn’s price target indicates a potential upside of 14.40% from the company’s previous close.

Other analysts have also issued research reports about the stock. Erste Group Bank raised shares of CME Group from a “hold” rating to a “strong-buy” rating in a research report on Thursday, March 5th. Raymond James Financial lowered their price target on shares of CME Group from $311.00 to $310.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 4th. Piper Sandler boosted their price target on shares of CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a research report on Thursday, November 13th. Barclays increased their price objective on shares of CME Group from $304.00 to $312.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 5th. Finally, JPMorgan Chase & Co. raised their price objective on CME Group from $262.00 to $266.00 and gave the company an “underweight” rating in a report on Thursday, February 5th. Two research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $303.53.

Check Out Our Latest Stock Report on CME Group

CME Group Stock Down 1.0%

NASDAQ:CME opened at $303.33 on Thursday. The stock has a 50-day simple moving average of $294.21 and a 200 day simple moving average of $278.44. CME Group has a 52-week low of $248.53 and a 52-week high of $329.16. The company has a market cap of $109.38 billion, a PE ratio of 27.18, a PEG ratio of 3.31 and a beta of 0.24. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.03 and a current ratio of 1.03.

CME Group (NASDAQ:CME – Get Free Report) last released its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 EPS for the quarter, beating the consensus estimate of $2.75 by $0.02. The firm had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.64 billion. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The business’s quarterly revenue was up 8.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.52 EPS. On average, sell-side analysts expect that CME Group will post 10.49 EPS for the current fiscal year.

Insider Activity

In other news, Director William R. Shepard bought 251 shares of the business’s stock in a transaction that occurred on Tuesday, December 30th. The stock was acquired at an average cost of $278.37 per share, for a total transaction of $69,870.87. Following the purchase, the director owned 258,710 shares of the company’s stock, valued at approximately $72,017,102.70. This trade represents a 0.10% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Martin J. Gepsman sold 300 shares of CME Group stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $305.90, for a total value of $91,770.00. Following the transaction, the director owned 24,999 shares of the company’s stock, valued at $7,647,194.10. The trade was a 1.19% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 5,248 shares of company stock worth $1,616,700. Insiders own 0.30% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in CME. Meadowbrook Advisors Group LLC acquired a new stake in CME Group during the 4th quarter valued at $2,166,000. Corient Private Wealth LLC raised its position in shares of CME Group by 20.0% in the fourth quarter. Corient Private Wealth LLC now owns 153,055 shares of the financial services provider’s stock valued at $41,815,000 after purchasing an additional 25,468 shares during the period. Auto Owners Insurance Co raised its position in shares of CME Group by 27,208.0% in the fourth quarter. Auto Owners Insurance Co now owns 534,964 shares of the financial services provider’s stock valued at $14,609,000 after purchasing an additional 533,005 shares during the period. Union Savings Bank acquired a new stake in shares of CME Group during the 4th quarter worth about $379,000. Finally, Storen Legacy Partners LLC acquired a new stake in shares of CME Group during the 4th quarter worth about $212,000. 87.75% of the stock is currently owned by institutional investors.

CME Group Company Profile

(Get Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

See Also